|
IFT81 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.171840E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.847100E-04 |
| Normal-vs-Stage2 |
2.258400E-03 |
| Normal-vs-Stage3 |
4.753900E-04 |
| Normal-vs-Stage4 |
4.29390000000751E-05 |
| Stage1-vs-Stage2 |
5.599200E-01 |
| Stage1-vs-Stage3 |
5.069000E-01 |
| Stage1-vs-Stage4 |
1.102770E-01 |
| Stage2-vs-Stage3 |
9.310200E-01 |
| Stage2-vs-Stage4 |
5.716400E-01 |
| Stage3-vs-Stage4 |
4.168600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.016500E-04 |
| Normal-vs-AfricanAmerican |
2.201200E-01 |
| Normal-vs-Asian |
6.196500E-02 |
| Caucasian-vs-AfricanAmerican |
1.887050E-01 |
| Caucasian-vs-Asian |
1.925790E-01 |
| AfricanAmerican-vs-Asian |
7.555200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.378900E-04 |
| Normal-vs-Female |
1.614770E-04 |
| Male-vs-Female |
8.303600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.163530E-03 |
| Normal-vs-Age(41-60Yrs) |
1.601560E-03 |
| Normal-vs-Age(61-80Yrs) |
5.59310000000091E-05 |
| Normal-vs-Age(81-100Yrs) |
5.060400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.992400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.395030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.539360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.402000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.355600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.971600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.151800E-01 |
| Classical-VS-Follicular |
3.060800E-01 |
| Classical-VS-Other |
9.268200E-01 |
| Classical-VS-Normal |
6.021200E-04 |
| Tall-VS-Follicular |
9.347400E-01 |
| Tall-VS-Other |
6.790000E-01 |
| Tall-VS-Normal |
3.396800E-03 |
| Follicular-VS-Other |
7.979200E-01 |
| Follicular-VS-Normal |
1.740930E-03 |
| Other-VS-Normal |
1.813190E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.65489999999613E-05 |
| Normal-vs-N1 |
1.401970E-02 |
| N0-vs-N1 |
3.474400E-01 |
|
|
